Brian K. Kaspar

Corporate Officer/Principal at The Ohio State University College of Medicine

Consumer Services

Health Technology

Profile

Brian K.
Kaspar is the founder of Milo Biotechnology LLC, which was founded in 2011.
He is currently an Associate Professor at The Ohio State University College of Medicine.
Previously, he worked as a Director & Chief Scientific Officer at Novartis Gene Therapies, Inc. Dr. Kaspar holds a doctorate degree from the University of California San Diego and an undergraduate degree from the University of Illinois.

Brian K. Kaspar active positions

Companies	Position	Start
The Ohio State University College of Medicine	Corporate Officer/Principal	-

All active positions of Brian K. Kaspar

Former positions of Brian K. Kaspar

Companies	Position	End
AVEXIS INC	Chief Tech/Sci/R&D Officer	2019-04-30
Milo Biotechnology LLC Milo Biotechnology LLC BiotechnologyHealth Technology Milo Biotechnology LLC develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The firm is targeting rare neuromuscular diseases, initiating a phase I/II clinical trial in Becker muscular dystrophy and inclusion body myositis. The company was founded by Al Hawkins and Brian K. Kaspar in January 2012 and is headquartered in Cleveland, OH.	Founder	-

See the detail of Brian K. Kaspar's experience

Training of Brian K. Kaspar

University of California San Diego	Doctorate Degree
University of Illinois	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian K. Kaspar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Milo Biotechnology LLC Milo Biotechnology LLC BiotechnologyHealth Technology Milo Biotechnology LLC develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The firm is targeting rare neuromuscular diseases, initiating a phase I/II clinical trial in Becker muscular dystrophy and inclusion body myositis. The company was founded by Al Hawkins and Brian K. Kaspar in January 2012 and is headquartered in Cleveland, OH.	Health Technology
Novartis Gene Therapies, Inc. Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL.	Health Technology